Efficacy and Safety of Androgen-Deprivation Therapy Combined with Docetaxel Plus Prednisone in High-Burden Metastatic Hormone-Sensitive Prostate Cancer

Efficacy and Safety of Androgen-Deprivation Therapy Combined with Docetaxel Plus Prednisone in High-Burden Metastatic Hormone-Sensitive Prostate Cancer

Linjun Hu,1,* Qinxin Zhao,2,* Hongsong Bai,1 Chengming Xie,1 Xingli Shan,1 Dehu Lu,1 Yonghai Chen,1 Dongdong Han,1 Zejun Xiao,2 Jun Tian,2 Dong Wang,2 Xingang Bi,2 Nianzeng Xing2 1Department of Urology, Cancer Hospital of HuanXing Chaoyang District Beijing, Beijing, People’s Republic of Ch...

Full description

Bibliographic Details
Main Authors: Hu L, Zhao Q, Bai H, Xie C, Shan X, Lu D, Chen Y, Han D, Xiao Z, Tian J, Wang D, Bi X, Xing N
Format: Article
Language:English
Published: Dove Medical Press 2020-06-01
Series:Cancer Management and Research
Subjects:
androgen-deprivation therapy
docetaxel
high-burden
metastatic hormone-sensitive
prostate cancer
Online Access:https://www.dovepress.com/efficacy-and-safety-of-androgen-deprivation-therapy-combined-with-doce-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/efficacy-and-safety-of-androgen-deprivation-therapy-combined-with-doce-peer-reviewed-article-CMAR

Similar Items